An Act Resolve establishing a special commission on psychedelic drug use for clinical trials and therapy
By Ms. DiZoglio (by request), a petition (accompanied by bill, Senate, No. 1282) of Matthew Crepeau for legislation to establish a special commission on psychedelic drug use for clinical trials and therapy. Mental Health, Substance Use and Recovery.
Bill Information
Bill Information
Presenting Legislator is not a sponsor of this measure.
- Presenter:
- Diana DiZoglio (By Request)
Bill History
| Date | Branch | Action |
|---|---|---|
| 3/29/2021 | Senate | Referred to the committee on Mental Health, Substance Use and Recovery |
| 3/29/2021 | House | House concurred |
| 7/8/2021 | Joint | Hearing scheduled for 07/19/2021 from 01:00 PM-05:00 PM in Virtual Hearing |
| 2/9/2022 | House | Reporting date extended to Monday May 9, 2022, pending concurrence |
| 3/24/2022 | Senate | Senate concurred |
| 5/12/2022 | House | Reporting date extended to Tuesday May 31, 2022, pending concurrence |
| 5/26/2022 | Senate | Senate concurred |
| 6/2/2022 | House | Reporting date extended to Thursday June 2, 2022, pending concurrence |
| 6/2/2022 | Senate | Senate concurred |
| 6/9/2022 | Senate | Accompanied a study order, see S2919 |
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.